SAT-LB16 Maintenance of Favorable Treatment Effect of Once-Weekly TransCon hGH for Children With Growth Hormone Deficiency: Interim Analysis From the Enlighten Long-Term Extension Trial

Background Once-weekly TransCon hGH is an investigational long-acting prodrug for growth hormone deficiency (GHD) that consists of 3 components: unmodified growth hormone (hGH; somatropin), an inert carrier that protects it, and a linker that temporarily binds the two. In the randomized phase 3 heiG...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Maniatis, Aristides K, Casella, Samuel J, Nadgir, Ulhas M, Mick, Gail J, Hofman, Paul, Saenger, Paul, Chertok, Elena D, Warshauer, Jeremy, Song, Wenjie, Peng, Jessica M, Komirenko, Allison S, Shu, Aimee D, Beckert, Michael, Aghajanova, Elena M, Thornton, Paul S
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Pediatric Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7209480/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2102
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars